ReNeuron Group plc
RENE.L · LSE
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | £530 | £403 | £257 | £6,065 |
| % Growth | 31.5% | 56.8% | -95.8% | – |
| Cost of Goods Sold | £267 | £324 | £9,503 | £16,335 |
| Gross Profit | £263 | £79 | -£9,246 | -£10,270 |
| % Margin | 49.6% | 19.6% | -3,597.7% | -169.3% |
| R&D Expenses | £4,463 | £8,068 | £6,004 | £16,335 |
| G&A Expenses | £1,132 | £1,127 | £728 | £1,914 |
| SG&A Expenses | £1,132 | £1,127 | £728 | £1,914 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £2,050 | £0 | £0 | £0 |
| Operating Expenses | £7,645 | £11,628 | £12,566 | £20,574 |
| Operating Income | -£7,115 | -£11,228 | -£12,914 | -£14,409 |
| % Margin | -1,342.5% | -2,786.1% | -5,024.9% | -237.6% |
| Other Income/Exp. Net | £458 | £170 | -£496 | £551 |
| Pre-Tax Income | -£6,657 | -£11,058 | -£13,410 | -£13,858 |
| Tax Expense | -£1,249 | -£1,369 | -£2,063 | -£2,446 |
| Net Income | -£5,408 | -£9,689 | -£11,347 | -£11,412 |
| % Margin | -1,020.4% | -2,404.2% | -4,415.2% | -188.2% |
| EPS | -0.095 | -0.17 | -0.29 | -0.35 |
| % Growth | 44.3% | 41.4% | 17.1% | – |
| EPS Diluted | -0.095 | -0.17 | -0.29 | -0.35 |
| Weighted Avg Shares Out | 57,126 | 56,976 | 39,129 | 32,671 |
| Weighted Avg Shares Out Dil | 57,126 | 56,976 | 39,129 | 32,671 |
| Supplemental Information | – | – | – | – |
| Interest Income | £153 | £29 | £20 | £287 |
| Interest Expense | £20 | £25 | £32 | £42 |
| Depreciation & Amortization | £267 | £324 | £380 | £412 |
| EBITDA | -£6,370 | -£10,709 | -£12,998 | -£13,404 |
| % Margin | -1,201.9% | -2,657.3% | -5,057.6% | -221% |